Novoste START's 386-Patient Beta-Cath In-Stent Restenosis Trial
This article was originally published in The Gray Sheet
Executive Summary
Novoste's in-stent restenosis trial for the Beta-Cath intracoronary radiation therapy system will enroll approximately 386 patients and will support a premarket approval application slated for submission in early 2000, the company says.